Alexander L. Johnson - 01 Feb 2024 Form 4/A Insider Report for CareDx, Inc. (CDNA)

Role
President of Patient and Testing Services
Signature
/s/ Alexander L. Johnson
Issuer symbol
CDNA
Transactions as of
01 Feb 2024
Net transactions value
$0
Form type
4/A
Filing time
09 Apr 2024, 17:42:09 UTC
Date Of Original Report
05 Feb 2024
Previous filing
30 Jan 2024
Next filing
06 Feb 2024
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction CDNA Common Stock Award $0 +174,520 +102% $0.000000 345,533 01 Feb 2024 Direct F1, F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 This amendment is being filed to report the grant of restricted stock units which was inadvertently omitted from the original Form 4 filed on February 5, 2024. This resulted in an additional 174,520 shares deemed beneficially owned by the Reporting Person which were inadvertently omitted from the original Form 4 and were also omitted from one Form 4 filed by the Reporting Person on February 6, 2024, which Form 4 should therefore have reflected a total of 344,413 shares deemed beneficially owned in Table I, Column 5.
F2 The reported securities are represented by restricted stock units, 1/12th of which shall vest on May 1, 2024 and 1/12th of which shall vest on each date that is three months thereafter.

Remarks:

President of Patient and Testing Services